Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Patient
87%
Promoter Region
65%
Inpatient
56%
Marker
56%
Blood
44%
Pancreas Cancer
40%
Gemcitabine
39%
Biological Marker
37%
Therapeutic Procedure
36%
Gene
30%
Neoplasm
25%
Pancreatic Ductal Adenocarcinoma
21%
Diagnosis
18%
Diabetes
18%
Plasma
18%
Cells
18%
DNA Methylation
18%
Radiation Therapy
18%
Cohort Analysis
18%
Adult
18%
Diagnostic Delay
18%
Eosinophilic Esophagitis
18%
Diseases
14%
Malignant Neoplasm
12%
Proportional Hazards Model
11%
Complication
10%
Serum
9%
Differentiation
9%
Radiation Oncologist
9%
Anatomy
9%
Oropharynx
9%
DNA Template
9%
Squamous Cell Carcinoma
9%
Adaptation
9%
Head and Neck Cancer
9%
Cancer Radiotherapy
9%
Diagnostic Marker
9%
Methylation
8%
Obstruction
8%
Log Rank Test
7%
Prognosis
7%
Maturity Onset Diabetes of the Young
6%
Cancer Staging
6%
Spontaneous Remission
5%
Treatment Response
5%
Polymerase Chain Reaction
5%
Biochemistry, Genetics and Molecular Biology
Gene
25%
DNA
23%
Gemcitabine
21%
Cohort Study
18%
Secreted Frizzled-Related Protein 1
18%
Methylation
11%
Bisulfite
7%
Polymerase Chain Reaction
7%
Glycosylated Hemoglobin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
22%
Pancreas Cancer
18%
Bisulfite
17%
Chemotherapy
15%
Complication
9%
Non Insulin Dependent Diabetes Mellitus
9%
Mortality
6%
Overall Survival
6%